Top Leading Companies in the Market 2025

Medtronic plc

• Headquarters: Dublin, Ireland
• Founded: 1949
• Employees: Approx. 95,000+
• 2024 Revenue: Approx. $32.4 billion
• Key Products: Drug-eluting stents, coronary balloons, and valves
• Regional Footprint: Strong in North America and emerging Asia-Pacific markets.

Boston Scientific Corporation

• Headquarters: Marlborough, Massachusetts, USA
• Founded: 1979
• Employees: Approx. 45,000
• 2024 Revenue: Approx. $14.2 billion
• Key Products: Coronary stents, imaging catheters
• Regional Focus: Extensive operations in the US, EU, and APAC.

Abbott Laboratories (Cardiovascular Division)

• Headquarters: Abbott Park, Illinois, USA
• Founded: 1888
• Employees: Approx. 115,000 (total)
• 2024 Revenue: Approx. $43.7 billion (total), Approx. $8.1B from cardiovascular division
• Key Products: Xience stents, MitraClip
• Markets: Global, especially strong in North America and Europe.

Terumo Corporation

• Headquarters: Tokyo, Japan
• Founded: 1921
• Employees: Approx. 26,000
• 2024 Revenue: Approx. $6.8 billion
• Focus: Guiding catheters, access systems, drug-coated balloons
• Markets: Japan, China, and expanding EU presence.

B. Braun Melsungen AG

• Headquarters: Melsungen, Germany
• Founded: 1839
• Employees: Approx. 65,000
• 2024 Revenue: Approx. $9 billion
• Specialty: Cardio-access systems, stent delivery technologies
• Regional Strength: Europe and Latin America.

Philips (Image-Guided Therapy Devices)

• Headquarters: Amsterdam, Netherlands
• Founded: 1891
• Employees: Approx. 75,000
• 2024 Revenue: Approx. $20 billion (HealthTech segment)
• Focus: Integrated cath lab solutions and imaging for interventional cardiology
• Presence: Strong in Europe and North America.

Edwards Lifesciences

• Headquarters: Irvine, California, USA
• Founded: 1958
• Employees: Approx. 17,000
• 2024 Revenue: Approx. $6.5 billion
• Known for: Transcatheter heart valves and structural heart solutions
• Markets: Strong EU and US penetration.

Biosensors International Group

• Headquarters: Singapore
• Founded: 1990
• Employees: Approx. 2,000
• 2024 Revenue: Approx. $400 million
• Specialty: BioMatrix stent series, DCBs
• Markets: Asia-Pacific and emerging markets.

Lepu Medical Technology

• Headquarters: Beijing, China
• Founded: 1999
• Employees: Approx. 10,000
• 2024 Revenue: Approx. $1.1 billion
• Key Offerings: Drug-eluting stents, vascular closure devices
• Expansion: Rapid growth in China, India, and Middle East.

Cardinal Health (Cordis)

• Headquarters: Miami Lakes, Florida, USA
• Acquired: Acquired from Cardinal Health in 2021
• Employees: Approx. 3,000
• 2024 Revenue: Approx. $700 million (est.)
• Products: Guiding catheters, PTA balloons
• Markets: Focus on North and South America.

Regional Analysis – 2025 Outlook

As cardiovascular disease continues to be the world’s leading cause of death, the global interventional cardiology market is primed for innovation and expansion. The above top 10 companies represent innovation, scalability, and geographical reach that will shape this space well beyond 2025.

Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE

About US:

Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.

Contact Us: IMIR Market Research Pvt. Ltd.

Follow Us: LinkedIn

Email: sales@intellectualmarketinsights.com

Call Us: +1 (814) 487 8486